Naomi, 50, Denied MS Treatment Due to Disease Duration: "I Don’t Want to Wait Until I’m in a Wheelchair"
Naomi, a 50-year-old Dutch woman, has been refused access to disease-modifying drugs (DMDs) for multiple sclerosis (MS) due to the lengthy duration of her condition, leaving her concerned about her future mobility.
Naomi was diagnosed with MS in 1999, making her condition one of the longest-standing cases in the Netherlands. DMDs, which slow down the progression of MS and reduce the frequency of relapses, are typically not prescribed to patients who have been living with the disease for an extended period, as they are deemed less effective.
Reflecting on her experience, Naomi expressed her disappointment and frustration with the current medical approach. She stated, "I find it unacceptable that someone with a long-term disease isn’t helped. I don’t want to wait until I’m in a wheelchair before I receive treatment."
The Dutch Health Care Institute (ZIN) and the Dutch Association of Neurology (NVN) maintain that DMDs are primarily designed for patients in the early stages of MS. However, both organizations recognize the complexity of the issue and the challenges faced by patients with long-term MS, emphasizing the importance of individual case evaluations.
Naomi’s story has sparked a conversation about the ethical implications and fairness of current treatment guidelines for patients with long-term MS. While medical advancements have significantly improved the quality of life for many MS patients, others with long-term cases face challenges accessing crucial treatments.
